Total synthesis of bioactive marine meroterpenoids: The cases of liphagal and frondosin B

16Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

Abstract

Liphagal and frondosin B are two marine-derived secondary metabolites sharing a very similar polyfused-benzofuran skeleton. The two tetracyclic meroterpenoids were isolated from marine sponges, both featuring a 6-5-7-6 fused ring system. A preliminary bioactive study shows that (+)-liphagal is a selective kinase (PI3K α) inhibitor, while (+)-frondosin B is shown to inhibit the binding of the cytokine interleukin-8 (IL-8) to its receptor, CX-CLR1/2. The unique structures and interesting biological profiles of these two meroterpenoids have attracted considerable attention from synthetic chemists. Herein we summarize the synthetic efforts with respect to (+)-liphagal and (+)-frondosin B during the past two decades.

Cite

CITATION STYLE

APA

Zong, Y., Wang, W., & Xu, T. (2018, April 1). Total synthesis of bioactive marine meroterpenoids: The cases of liphagal and frondosin B. Marine Drugs. MDPI AG. https://doi.org/10.3390/md16040115

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free